Prosecution Insights
Last updated: October 04, 2026

Kumiai Chemical Industry Co., Ltd.

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

Kumiai Chemical Industry Co., Ltd. currently manages 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 4 distinct examiners, providing a variety of perspectives on the company's patent applications. Nizal S Chandrakumar is the busiest examiner for the portfolio, overseeing 1 pending office action. The portfolio also spans 4 distinct art units.

For a practitioner, the distribution of 4 pending office actions across different examiners suggests that the portfolio is not dependent on a single individual's interpretation. The focus on the Biotechnology & Pharmaceuticals technology area indicates a specialized technical direction. Because 4 distinct art units are involved, the company may encounter varying examination standards, which requires a coordinated prosecution approach.

Managing the distinct examiners requires a proactive approach to ensure that responses are aligned with the overall strategic goals of the company. Practitioners should analyze the allowance rates and prosecution timelines for each assigned examiner to better predict the outcomes for these pending matters. This approach helps in navigating the complexities of the biotechnology patent landscape where examiner discretion can be significant. Maintaining a unified legal position across different examiners is essential for a strong intellectual property portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (25%)
2
Medium (50%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
§112 only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHANDRAKUMAR, NIZAL S 1 72.7% +18.3%
STOCKTON, LAURA LYNNE 1 75.2% +33.7%
JUSTICE, GINA CHIEUN YU 1 55.6% +8.4%
HIRT, ERIN E 1 40.3% +23.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18258906 SULFONE DERIVATIVE PRODUCTION METHOD STOCKTON, LAURA LYNNE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18578919 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT CHANDRAKUMAR, NIZAL S —
18258906 SULFONE DERIVATIVE PRODUCTION METHOD STOCKTON, LAURA LYNNE —
17289112 METHOD FOR CONTROLLING DISEASES IN SMALL GRAIN CEREALS, SEED OF SMALL GRAIN CEREALS, AND METHOD FOR SUPPRESSING LODGING DAMAGE IN SMALL GRAIN CEREALS HIRT, ERIN E —

Top Art Units

Art UnitApps
1625 1
1626 1
1617 1
1616 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18578919 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT CHANDRAKUMAR, NIZAL S 1625 §112 Non-Final OA — Pending Jan 12, 2024
18258906 SULFONE DERIVATIVE PRODUCTION METHOD STOCKTON, LAURA LYNNE 1626 §102§103§112 Non-Final OA — Pending Jun 22, 2023
17771169 AGROCHEMICAL COMPOSITION FOR SOIL TREATMENT AND PEST CONTROL METHOD USING SAME JUSTICE, GINA CHIEUN YU 1617 §103 Final Rejection 13d Pending Apr 22, 2022
17289112 METHOD FOR CONTROLLING DISEASES IN SMALL GRAIN CEREALS, SEED OF SMALL GRAIN CEREALS, AND METHOD FOR SUPPRESSING LODGING DAMAGE IN SMALL GRAIN CEREALS HIRT, ERIN E 1616 §103Other Non-Final OA — Pending Apr 27, 2021

Managing Kumiai Chemical Industry Co., Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month